Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598728 · ClinicalTrials.gov registry record
Quality of Life Among Survivors of Hodgkin Lymphoma
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 255
- Enrollment target
NCT00598728: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00598728 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598728 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.
Interventions
- BEHAVIORAL Quality of Life Questionaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2005-05 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00598728
The ClinicalTrials.gov registry entry for NCT00598728 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quality of Life Questionaires is the first listed.
NCT00598728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00598728 about?
NCT00598728 is a clinical study titled "Quality of Life Among Survivors of Hodgkin Lymphoma". The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.
What is the current status of trial NCT00598728?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2005-05. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00598728?
The interventions under investigation include: Quality of Life Questionaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00598728?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.